ArticleJournal of cancer research and clinical oncology2022

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study.

Song Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.